Sickle cell disease is one of those conditions people often think they understand until genetics strolls in, pulls up a chair, and says, “Actually, let’s talk inheritance.” The short version is this: sickle cell disease is not contagious, not caused by diet, and not something you develop because life has a twisted sense of humor. It is an inherited blood disorder that begins at birth.
Still, the question “Who gets sickle cell disease?” deserves a better answer than a one-liner. The disease can affect people of any ethnicity, but some groups are more likely to carry the gene changes that cause it. Family history matters. Ancestry matters. Partner screening matters. And understanding the difference between sickle cell disease and sickle cell trait matters a whole lot more than most people realize.
In this guide, we will break down who is at risk for sickle cell disease, why certain populations are affected more often, how inheritance works, what symptoms and complications can look like, and how screening helps families make informed choices. Think of this as your plain-English, no-nonsense, medically grounded guide to sickle cell disease risk groups and the bigger picture around them.
What is sickle cell disease, exactly?
Sickle cell disease, often shortened to SCD, is a group of inherited red blood cell disorders. Normally, red blood cells are round and flexible, which lets them move smoothly through blood vessels and deliver oxygen where it is needed. In sickle cell disease, abnormal hemoglobin causes those cells to become stiff, sticky, and crescent-shaped. That is where the word “sickle” comes from.
Those misshapen cells do not play nicely with circulation. They can break apart too early, which causes anemia, and they can also clog small blood vessels, which can trigger pain crises and serious complications. Sickle cell disease is not just “an anemia problem.” It can affect the lungs, brain, kidneys, spleen, eyes, bones, and more.
Another important point: sickle cell disease is not one single diagnosis. It includes several types, including HbSS (often called sickle cell anemia), HbSC, and forms involving beta thalassemia. Some types are usually more severe than others, so two people with “sickle cell disease” may have very different medical experiences.
Who gets sickle cell disease?
The most accurate answer is this: people who inherit certain hemoglobin gene changes from their parents get sickle cell disease. That means the biggest risk factor is genetic inheritance, not lifestyle, not environment, and definitely not bad vibes.
It is inherited from both sides of the family
Most often, a person gets sickle cell disease when they inherit a sickle hemoglobin gene from both parents, or a sickle gene from one parent and another abnormal hemoglobin gene from the other parent, such as hemoglobin C or beta thalassemia. That is why family history matters so much.
If both parents have sickle cell trait, each pregnancy carries the same set of odds: a 25% chance of a child with sickle cell disease, a 50% chance of a child with sickle cell trait, and a 25% chance of a child with neither. Genetics does not “remember” previous pregnancies, so the odds reset each time. DNA is many things, but sentimental is not one of them.
Some ancestry groups are affected more often
Although anyone can inherit the gene changes linked to sickle cell disease, the condition is more common in people whose families come from regions where malaria has historically been common. That includes parts of Africa, the Mediterranean, the Middle East, India, and parts of Central and South America and the Caribbean.
In the United States, sickle cell disease is seen most often in Black or African American populations, but it also affects Hispanic people and people from Middle Eastern, South Asian, and Mediterranean backgrounds. The key idea here is ancestry, not a rigid box-checking exercise. A person does not need to “look like” a stereotype to carry a sickle cell gene.
That matters because families are often more diverse than medical assumptions. Someone may not realize sickle cell disease is part of their reproductive risk story until a baby is diagnosed or carrier testing reveals it. That is one reason universal or broader hemoglobinopathy screening has become such an important conversation in reproductive care.
Family history raises the stakes
If you have a parent, sibling, or close relative with sickle cell disease or sickle cell trait, your own chance of being a carrier is higher than average. This is especially important for people planning pregnancy. Many carriers feel healthy and have no idea they carry the gene unless they are tested.
That is why “I feel fine” is not a reliable screening method. It works for choosing a sandwich. It does not work for inherited blood disorders.
Sickle cell disease vs. sickle cell trait
This distinction is huge. Sickle cell disease means a person has inherited two affected hemoglobin genes or one sickle gene plus another abnormal hemoglobin gene. Sickle cell trait means a person has inherited only one sickle gene and one normal hemoglobin gene.
Most people with sickle cell trait do not have the disease and generally live normal lives without the same complications seen in sickle cell disease. Trait does not turn into disease later. However, trait still matters because carriers can pass the gene to their children. Rarely, under extreme conditions such as severe dehydration, high altitude, or very intense physical exertion, people with sickle cell trait may face complications.
In the U.S., sickle cell trait is far more common than sickle cell disease. That is why family planning, education, and accurate testing are such a big part of the conversation.
Which groups are considered higher risk in the United States?
When people ask about sickle cell disease risk groups, they are usually asking which populations are more likely to have the disease or carry the sickle cell gene. In the U.S., the highest-risk groups include:
- Black or African American individuals and families
- People with Caribbean ancestry
- Hispanic individuals whose family roots trace to Central or South America
- People with Mediterranean ancestry, including Southern European backgrounds
- People with Middle Eastern ancestry
- People with South Asian or Indian ancestry
- Anyone with a known family history of sickle cell disease or sickle cell trait
In U.S. data, sickle cell disease occurs in about 1 in 365 Black or African American births, and sickle cell trait occurs in about 1 in 13 Black or African American births. Hispanic Americans are also affected, though at lower rates overall than Black Americans. These numbers are useful for public health, but they should never be used to erase the fact that sickle cell genes can appear in many populations.
How and when is sickle cell disease found?
One reason more children are diagnosed early today is that newborn screening is standard in the United States. Babies are screened shortly after birth for sickle cell disease and related hemoglobin disorders. Early detection matters because symptoms often start during the first year of life, usually around 5 to 6 months of age, and early treatment can reduce dangerous complications.
Testing is also available before or during pregnancy. Carrier screening may be done with blood tests such as hemoglobin electrophoresis or molecular genetic testing. This helps identify whether one or both parents carry a sickle cell gene or another hemoglobin variant.
For people planning pregnancy, this information can be incredibly valuable. It does not tell families what they “must” do. It gives them choices, clarity, and time to talk with healthcare professionals or genetic counselors before they are making decisions in the middle of emotional chaos.
What symptoms and complications can shape the disease?
Sickle cell disease is present at birth, but symptoms often appear later in infancy. Common early and ongoing problems can include anemia, fatigue, jaundice, painful swelling of the hands and feet, and repeated pain episodes. Over time, people may also develop chronic pain, frequent infections, delayed growth, eye problems, and organ complications.
More serious complications can include acute chest syndrome, stroke, kidney problems, spleen damage, bone injury, and long-term damage to multiple organs. Severity varies widely. Some people have relatively fewer crises; others deal with repeated hospital visits and daily symptoms that disrupt school, work, sleep, and relationships.
That variation is why broad assumptions are so unhelpful. You cannot look at someone and know how sickle cell disease affects them. It is a deeply individual condition, even within the same family.
What lowers risk and improves outcomes?
You cannot prevent someone from inheriting sickle cell disease after conception, but you can improve outcomes with early diagnosis, good medical follow-up, and disease-specific treatment. Children often benefit from vaccines, penicillin prophylaxis, and regular monitoring. A medication called hydroxyurea can reduce pain crises and other complications for many patients. Some people also need blood transfusions.
For selected patients, especially in severe cases, bone marrow or stem cell transplant may offer a potential cure. There are also FDA-approved cell-based gene therapies for certain patients age 12 and older with serious disease. These newer options are exciting, but they are complex, highly specialized, and not the right fit for every person.
Good care also includes practical basics: staying hydrated, avoiding extreme temperatures when possible, managing infections quickly, keeping regular appointments, and having a plan for pain episodes. In other words, the care plan is both high-tech and human.
Why reproductive screening and counseling matter
Because sickle cell disease is inherited, conversations about pregnancy matter a great deal. A person can carry sickle cell trait and never know it unless tested. That is why screening before pregnancy or at the first prenatal visit can be so helpful. If both partners are carriers of sickle-related hemoglobin variants, a genetic counselor can explain the odds and discuss available options.
This is not about fear. It is about informed choice. For many families, the most stressful part is not the test result itself but the shock of finding out too late that they did not know their own carrier status. Knowledge may not solve every problem, but it usually gives people a much better map.
What living with sickle cell disease can feel like: real-world experiences and patterns
To understand who gets sickle cell disease, it helps to also understand what life with the condition can feel like. The lived experience is not just a list of lab values and textbook complications. For many people, sickle cell disease is a condition that interrupts ordinary moments in very unordinary ways.
One common experience is unpredictability. A person may wake up feeling completely normal and end the day in severe pain. Pain crises can happen in the chest, back, arms, legs, or joints, and they do not care whether someone has a school exam, a work deadline, or vacation plans they have been looking forward to for six months. That unpredictability can create anxiety even on good days, because feeling okay does not always mean staying okay.
Another common experience is exhaustion. Chronic anemia can make people feel drained in a way that others do not always understand. This is not regular tiredness that disappears after a latte and a motivational playlist. It can be a deep physical fatigue that affects concentration, stamina, exercise, and daily routines. Children may have trouble keeping up with peers. Adults may need to carefully pace themselves at work or at home.
Many families also describe the emotional weight of frequent medical care. Hospital visits, emergency evaluations, blood tests, medications, specialist appointments, and insurance paperwork can become part of normal life. Parents may feel like they are always half-packed for a possible trip to the hospital. Teens and young adults may struggle with the shift from pediatric care to adult care, especially when they are also trying to build independence.
Social experiences can be complicated too. Because symptoms are not always visible, people with sickle cell disease are sometimes misunderstood. A student may look “fine” but be in pain. An employee may need time off for a crisis and worry that coworkers assume they are unreliable. Some patients report feeling dismissed when they seek treatment for pain, which can add frustration and mistrust to an already difficult moment.
There is also the family-planning side of the experience. People with sickle cell trait often discover their status during pregnancy screening or after a child is diagnosed. That can bring guilt, confusion, or a lot of questions, even though no one “caused” the condition on purpose. For families with a strong history of sickle cell disease, the topic can become part of how relationships, marriage, and pregnancy conversations unfold over time.
At the same time, the lived experience is not only hardship. Many people with sickle cell disease build full, meaningful lives with school, careers, parenting, sports, friendships, and long-term goals. Better screening, better preventive care, hydroxyurea, transfusion protocols, transplant advances, and newer gene-based therapies are changing what care can look like. Advocacy has also helped push the medical system to take pain, equity, and access more seriously.
So when we ask who gets sickle cell disease, the answer is not just a demographic category. It is babies identified through newborn screening. It is teens learning to manage pain and appointments. It is adults balancing work and chronic symptoms. It is parents learning carrier genetics. It is families building resilience while navigating a disease that is both inherited and deeply personal.
Conclusion
So, who gets sickle cell disease? People get sickle cell disease when they inherit the relevant hemoglobin gene changes from their parents. The disease can affect anyone, but it is more common in people with African, Caribbean, Hispanic, Mediterranean, Middle Eastern, and South Asian ancestry, as well as in people with a family history of sickle cell disease or trait.
The most important takeaway is that risk is not just about race labels. It is about inheritance, ancestry, screening, and awareness. Knowing the difference between sickle cell disease and sickle cell trait, getting tested when appropriate, and using newborn or reproductive screening wisely can make a real difference for individuals and families.
And if genetics has taught us anything, it is this: your family story may be more informative than your assumptions. When it comes to sickle cell disease, that knowledge can be powerful.